CLINICAL_TRIALS
trial_result
· 2018-05-02
Clinical Trial Update: Trial of L-DOPA as a Treatment to Improve Vision in Albinism [Phase 2]
Summary
Phase 2 clinical trial evaluating L-DOPA for improving vision in individuals with albinism; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Minnesota | Conditions: Albinism | Phase 2 | Status: COMPLETED | Results posted: 2018-05-02